Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.92% | 2.50% | -1.33% | 3.05% | 12.82% |
| Total Depreciation and Amortization | 1.30% | 7.20% | 19.70% | 35.64% | 48.51% |
| Total Amortization of Deferred Charges | -2.49% | -0.85% | 6.42% | 16.08% | 42.60% |
| Total Other Non-Cash Items | 26.43% | 29.49% | 34.10% | 41.02% | 47.73% |
| Change in Net Operating Assets | -300.52% | -233.37% | -130.88% | 32.18% | 6.21% |
| Cash from Operations | -40.24% | -17.28% | 1.74% | 36.34% | 43.77% |
| Capital Expenditure | 20.51% | 50.06% | 69.89% | 57.66% | 61.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.84% | 104.03% | 96.39% | -194.24% | -3,108.34% |
| Cash from Investing | 109.24% | 102.90% | 95.57% | -157.88% | -7,429.84% |
| Total Debt Issued | -- | -- | -- | -101.45% | -101.45% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -87.69% | -97.60% | -96.61% | 2,283.54% | 1,927.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 203.01% | 203.41% |
| Cash from Financing | -87.68% | -98.03% | -97.22% | 285.16% | 275.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.31% | 35.37% | 35.75% | 59.07% | -316.16% |
